All Posts
Join the Future of Medicine: ASGCT 2026 Annual Meeting in Boston
The field of genetic and cellular medicines is advancing at an unprecedented pace, and there
March 31, 2026
The field of genetic and cellular medicines is advancing at an unprecedented pace, and there
Managing the lifecycle of Investigational Medicinal Products (IMP) requires more than just logistics; it demands
In the modern drug development world, the transition from clinical phases to commercial viability is
In pharmaceutical development, a stability study is never a mere paperwork exercise. It is the
FOR IMMEDIATE RELEASE DES Pharma to Attend DCAT Week 2026 in New York City Engineering Confidence in
Our latest episode from The DES Pharma podcast explores the rapidly changing trade policy landscape
This guide establishes a clear, phase-appropriate framework for how Analytical Development (AD) and Quality Control
The pharmaceutical landscape is shifting beneath our feet. As the industry prepares for DCAT Week
Navigate U.S. tariffs and pharmaceutical supply chains in 2026 — Section 232, IEEPA, USMCA, MFN
Analytical Development vs Process Development: Integrated CMC Strategy Across Drug Development Phases In pharmaceutical and
Start building reliable, high-quality drug development programs today.